SignatureFD’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-12
Closed -$422 3282
2024
Q1
$422 Buy
+12
New +$402 ﹤0.01% 3047
2023
Q4
Sell
-141
Closed -$3.23K 3307
2023
Q3
$3.23K Sell
141
-5
-3% -$262 ﹤0.01% 2634
2023
Q2
$8.37K Sell
146
-22
-13% -$1.15K ﹤0.01% 2315
2023
Q1
$6.32K Buy
168
+27
+19% +$995 ﹤0.01% 2410
2022
Q4
$3.77K Sell
141
-102
-42% -$2.79K ﹤0.01% 2586
2022
Q3
$7K Buy
243
+102
+72% +$2.84K ﹤0.01% 2300
2022
Q2
$3K Buy
+141
New +$3.94K ﹤0.01% 2685
2022
Q1
Sell
-4
Closed 3365
2021
Q4
$0 Buy
+4
New +$215 ﹤0.01% 3308
2021
Q3
Sell
-13
Closed -$1K 3247
2021
Q2
$1K Buy
+13
New +$715 ﹤0.01% 2878

Other funds holding MORF

SignatureFD's MORF Position: Q2 2024 in Review

SignatureFD sold out of Morphic Holding, Inc. Common Stock (MORF) in Q2 2024, closing a stake of 12 shares — an estimated $422 sold.

SignatureFD first reported a position in MORF in Q2 2021 and held it in 9 quarters. The position peaked at $8.37K in Q2 2023. 136 funds tracked by Wall St. Rank hold MORF as of Q2 2024.

  • SignatureFD reported no remaining Morphic Holding, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • SignatureFD sold 12 Morphic Holding, Inc. Common Stock shares in Q2 2024, an estimated $422.
  • SignatureFD first reported a position in Morphic Holding, Inc. Common Stock in Q2 2021 and held it in 9 quarters.
  • SignatureFD's Morphic Holding, Inc. Common Stock position peaked at $8.37K in Q2 2023.
  • 136 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q2 2024.

Based on SignatureFD's 13F filing for Q2 2024, filed 29 Jul 2024.